PURPOSE
=======

To create a simple algorithm of choice for bilateral mastectomy in female-to-male transsexuals.

METHODS
=======

On the basis of our clinical experience of more than 400 bilateral mastectomies performed since 1993, we distinguish 3 different approaches: Type 1, bilateral subcutaneous mastectomy performed through semicircular incision at the border nipple-areola complex; Type 2, bilateral subcutaneous mastectomy with circular deepithelization around the nipple-areola complex, which is performed to correct skin excess; and Type 3 bilateral mastectomy with autotransplantation of the nipple-areola complex. Every patient was registered in a clinical study, medical photographs were taken, and clinical follow-up was performed before surgery and 2 weeks, 1 month, 3 months, 6 months, and 12 months after surgery. Every patient has completed a clinical questionnaire, which includes a quality of life survey.

RESULTS
=======

From October 2012 to March 2015 in our department, 61 bilateral mastectomies were performed: Type 1, 14 (23.0%); Type 2, 16 (26.2%); and Type 3, 31 (50.8%). Complications encountered were divided into early or late ones. Early complications, which occurred in the first 2 weeks, included hematoma, 7 (11.4%); seroma formation, 12 (19.6%); partial necrosis of the nipple-areola complex, 3 (4.9%); and ligature inflammation, 2 (3.2%). Late complications (after 2 weeks) included hypertrophic scar formation, 4 (6.5%); folliculitis in area of postoperative scar after deepithelization, 3 (4.9%); and hypersensitivity of the nipples, 1 (1.6%). Patient satisfaction rate is 90%. In 6 cases (10%), secondary surgical corrections were performed. In most cases, correction included scar revision with simultaneous lipofilling of anterior chest-wall deformities.

CONCLUSIONS
===========

In many cases, the selection of the right type of bilateral mastectomy for the right patient is difficult. In our practice, we use our own algorithm of choice, which is based on the breast size, breast ptosis, skin elasticity, and the risk factors: In patients with small breast size (A) without ptosis and with good skin elasticity without risk factors, we perform Type 1 surgery. In patients with moderate breast size (B) with good skin elasticity, we perform Type 2 bilateral mastectomy. In cases of large breasts (C, D, and E), we perform Type 3 procedure. For patients with moderate breast size (B) with moderate ptosis, Type 2 surgery is performed if there are no additional risk factors to the blood supply of the nipple-areola complex. Type 3 surgery is chosen for this kind of breast size (B) in case of long-term smoking, breast-bandaging history, tuberous breasts, anterior chest-wall scaring, and severe ptosis. Despite the long residual scars, patients often prefer Type 3 surgery because it provides the best contour and ideal nipple-areola complex position after 1 procedure. In most cases, it is impossible to remove all of the skin excess when performing Type 2 bilateral mastectomy, and secondary correction surgery is required. The most dangerous complication of those procedures is hematoma, which usually requires surgical treatment. The frequency of this complication drops as we move from Type 1 to Type 3 in our algorithm because of better wound exposure and increasing simplicity of hemostasis.
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